Showing results (1-10 of 320) with videos related to
Sort By:
Pageof 32
The International Journal of Risk & Safety in Medicine|December 8, 2015
Human butyrylcholinesterase polymorphism: Molecular modelingS Lushchekina, H Delacour, O Lockridge, et al.Neurotoxicology|May 4, 2000
Pesticides and susceptible populations: people with butyrylcholinesterase genetic variants may be at riskO Lockridge, P MassonFEBS Letters|March 12, 1990
Evidence for a single butyrylcholinesterase gene in individuals carrying the C5 plasma cholinesterase variant (CHE2)P Masson, A Chatonnet, O LockridgeBiochimica Et Biophysica Acta|September 28, 1998
Resistance of butyrylcholinesterase to inactivation by ultrasound: effects of ultrasound on catalytic activity and subunit associationM T Froment, O Lockridge, P MassonChemico-Biological Interactions|July 27, 1999
Human serum paraoxonase (PON1): identification of essential amino acid residues by group-selective labelling and site-directed mutagenesisD Josse, W Xie, P Masson, et al.The Journal of Biological Chemistry|July 5, 1993
Recombinant human butyrylcholinesterase G390V, the fluoride-2 variant, expressed in Chinese hamster ovary cells, is a low affinity variantP Masson, S Adkins, P Gouet, et al.Biochimica Et Biophysica Acta|May 9, 2001
Effects of mutations of active site residues and amino acids interacting with the Omega loop on substrate activation of butyrylcholinesteraseP Masson, W Xie, M T Froment, et al.European Journal of Biochemistry|January 15, 1996
Asp7O in the peripheral anionic site of human butyrylcholinesteraseP Masson, M T Froment, C F Bartels, et al.The Biochemical Journal|July 1, 1997
Importance of aspartate-70 in organophosphate inhibition, oxime re-activation and aging of human butyrylcholinesteraseP Masson, M T Froment, C F Bartels, et al.Annales Pharmaceutiques Francaises|April 27, 2002
[Inactivation of bacterial spores by high hydrostatic pressure]H Delacour, C Cléry, P Masson, et al.Pageof 32